Singapore Markets closed

23andMe Holding Co. (ME)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.9300-0.0800 (-2.66%)
At close: 04:00PM EDT
3.0200 +0.09 (+3.07%)
Pre-market: 09:11AM EDT
Full screen
Loading interactive chart…
  • Motley Fool

    23andMe CEO Anne Wojcicki on Bringing Health Information Directly to People

    In this podcast, Motley Fool contributor Brian Orelli interviews Anne Wojcicki, the CEO of 23andMe (NASDAQ: ME), about her company and why it's looking to tell you much more than the names of your long-lost relatives. To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. Anne Wojcicki: [MUSIC] When I think one of our legacies, hopefully, will be, is that 23andme has really proven that complicated information can go direct to a consumer, it does not have to have a one-to-one interaction with the physician.

  • Motley Fool

    This Exciting Biotech Stock Could Be Your Next 10-Bagger

    The stock performance of 23andMe (NASDAQ: ME) has plunged since it went public last June. But, in this video clip from "The Rank" on Motley Fool Live, recorded on March 28, Fool.com contributors Matt Frankel and Travis Hoium discuss a few of the biotech company's promising business plans that could pay off in a big way over the next few years.

  • Motley Fool

    2 Beaten-Down SPACs That Could Be Long-Term Home Runs

    This is especially true when it comes to companies that went public through special purpose acquisition companies, or SPACs, in the past couple of years. Offerpad Solutions (NYSE: OPAD) is an iBuyer that went public through a blank check company, or SPAC, in 2021, and like many SPAC IPOs, the stock has been hammered since going public.